[Comment] A new option for remission induction in acute myeloid leukaemia

Treatment of haematological malignancies has improved substantially over the past two decades; survival times have doubled and the prospect of cure of several diseases is based on the introduction of novel drugs. However, acute myeloid leukaemia was a notable exception with few new treatments available.1 Survival in this disease has remained dismal, especially in elderly patients with acute myeloid leukaemia not eligible for intensive induction chemotherapy. This situation was mainly due to the fact that the survival benefit from treatment of acute myeloid leukaemia was limited to patients who achieved complete remission or, at least, blast clearance.
Source: The Lancet Oncology - Category: Cancer & Oncology Authors: Tags: Comment Source Type: research